Step-down and step-up therapy in moderate persistent asthma

International Archives of Allergy and Immunology

Volumn 124, Issue 1-3, 2001, Pages 414-416

  Adachi, Mitsuru ^a   Kohno, Yasurou ^a   Minoguchi, Kenji ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Asthma; Exacerbation; Inhaled steroid

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; PREDNISOLONE; STEROID;

ASTHMA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADMINISTRATION, INHALATION; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; DESENSITIZATION, IMMUNOLOGIC; FORCED EXPIRATORY VOLUME; HUMANS; PEAK EXPIRATORY FLOW RATE; PULMONARY EOSINOPHILIA; SPUTUM;

EID: 0035053121     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053774     Document Type: Conference Paper

References (7)

1. Eosinophilic inflammation in asthma
2. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma
3. British guidelines on asthma management. 1995 review and position statement
4. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment
5. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment
6. Effect of inhaled formoterol and budesonide on exacerbations of asthma